Pre-made Ustekinumab biosimilar ( Whole mAb, anti-IL12B therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-605
Anti-IL12B therapeutic antibody (Pre-made Ustekinumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Ustekinumab, sold under the brand name Stelara?, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both IL-12 and IL-23.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-IL12B therapeutic antibody (Pre-made Ustekinumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||3hmw:HL/3hmx:HL|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Centocor Inc;Janssen Biotech;Medarex|
|Conditions Approved||Crohn's disease;Plaque psoriasis;Psoriatic arthritis|
|Conditions Active||Ulcerative colitis;Spondylarthritis;Systemic lupus erythematosus;Atopic dermatitis|
|Conditions Discontinued||Multiple sclerosis;Palmoplantar pustulosis;Primary biliary cirrhosis;Rheumatoid arthritis;Sarcoidosis|
|Development Tech||Medarex UltiMAb Mouse|